PODXL
protein-codingpodocalyxin like
Gene summary
This gene encodes a member of the sialomucin protein family. The encoded protein was originally identified as an important component of glomerular podocytes. Podocytes are highly differentiated epithelial cells with interdigitating foot processes covering the outer aspect of the glomerular basement membrane. Other biological activities of the encoded protein include: binding in a membrane protein complex with Na+/H+ exchanger regulatory factor to intracellular cytoskeletal elements, playing a role in hematopoetic cell differentiation, and being expressed in vascular endothelium cells and binding to L-selectin. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~58.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0000828
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0005377
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0005377
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0017279
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0018321
Submitter: Orphanet
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PODXL variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001018111.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 62 | 10 | 73 | ||
| missense | 106 | 28 | 2 | 136 | ||
| nonsense | 3 | 3 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | 2 | 6 | |
| splice donor/acceptor (+/-2bp) | 2 | 4 | 6 | |||
| Total | 4 | 3 | 113 | 90 | 14 | 224 |
Highest pathogenic variant AF is 0.00000929383
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001018121.1 | 9 | MANE Select | |
| Ensembl | ENSP00000367817.3 | 9 | MANE Select | |
| RefSeq | NP_005388.2 | 8 | Standard | |
| Ensembl | ENSP00000319782.9 | 8 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| podxl | Danio rerio | Structure: pronephric glomerular capsule Quality: cystic abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- miR-targeted genes in epithelium - TarBase
- miR-targeted genes in muscle cell - TarBase
- miR-targeted genes in squamous cell - TarBase
- Primary Focal Segmental Glomerulosclerosis FSGS
- Ectoderm Differentiation
Biological Process
- cell adhesion
- negative regulation of cell adhesion
- cell migration
- negative regulation of cell-cell adhesion
- positive regulation of cell migration
Molecular Function
- protein binding
Cellular Component
- ruffle
- extracellular space
- nucleolus
- cytoplasm
- microtubule organizing center
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000378555
- Coding exons
- 9
- Length
- 57956
- Individuals with no LoFs
- 125738
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 10
- Defined
- 125748
- p
- 0.0000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.672 | 271 | 304 | 0.891 | 0.0000169 | 3541 |
| Missense (PolyPhen) | 65 | 82.487 | 0.78801 | 1003 | ||
| Synonymous | 0.121 | 135 | 137 | 0.987 | 0.00000892 | 1196 |
| Loss of Function | 2.69 | 9 | 22.9 | 0.394 | 0.00000135 | 247 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000044 | 0.000044 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in the regulation of both adhesion and cell morphology and cancer progression. Function as an anti-adhesive molecule that maintains an open filtration pathway between neighboring foot processes in the podocyte by charge repulsion. Acts as a pro-adhesive molecule, enhancing the adherence of cells to immobilized ligands, increasing the rate of migration and cell- cell contacts in an integrin-dependent manner. Induces the formation of apical actin-dependent microvilli. Involved in the formation of a preapical plasma membrane subdomain to set up initial epithelial polarization and the apical lumen formation during renal tubulogenesis. Plays a role in cancer development and aggressiveness by inducing cell migration and invasion through its interaction with the actin-binding protein EZR. Affects EZR- dependent signaling events, leading to increased activities of the MAPK and PI3K pathways in cancer cells. {ECO:0000269|PubMed:17616675, ECO:0000269|PubMed:18456258}.;
Recessive Scores
- pRec
- 0.0901
Intolerance Scores
- LoFtool
- 0.580
- RVIS EVS
- 1.38
- RVIS percentile EVS
- 94.6
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.450
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |